GGCT has been reported to be upregulated in several cancers, and depletion of GGCT can exert anticancer effects in these cancers, including prostate, esophageal squamous cell carcinoma, breast, gastric, and ovarian cancers [23,41,42,43,44]. This evidence concerns the gene GGCT and ovarian carcinoma.